- Home
- QLGN vs ICCT Comparison
QLGN vs ICCT Comparison
Compare QLGN & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- ICCT
- Stock Information
- Founded
- QLGN 1996
- ICCT 1992
- Country
- QLGN United States
- ICCT United States
- Employees
- QLGN N/A
- ICCT N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- ICCT Computer Software: Prepackaged Software
- Sector
- QLGN Health Care
- ICCT Technology
- Exchange
- QLGN Nasdaq
- ICCT Nasdaq
- Market Cap
- QLGN 3.2M
- ICCT 2.9M
- IPO Year
- QLGN N/A
- ICCT N/A
- Fundamental
- Price
- QLGN $4.07
- ICCT $2.50
- Analyst Decision
- QLGN
- ICCT
- Analyst Count
- QLGN 0
- ICCT 0
- Target Price
- QLGN N/A
- ICCT N/A
- AVG Volume (30 Days)
- QLGN 20.7K
- ICCT 142.3K
- Earning Date
- QLGN 11-14-2024
- ICCT 11-19-2024
- Dividend Yield
- QLGN N/A
- ICCT N/A
- EPS Growth
- QLGN N/A
- ICCT N/A
- EPS
- QLGN N/A
- ICCT N/A
- Revenue
- QLGN N/A
- ICCT $11,049,477.00
- Revenue This Year
- QLGN N/A
- ICCT N/A
- Revenue Next Year
- QLGN N/A
- ICCT N/A
- P/E Ratio
- QLGN N/A
- ICCT N/A
- Revenue Growth
- QLGN N/A
- ICCT 42.66
- 52 Week Low
- QLGN $3.34
- ICCT $2.25
- 52 Week High
- QLGN $29.45
- ICCT $37.40
- Technical
- Relative Strength Index (RSI)
- QLGN 45.00
- ICCT 42.24
- Support Level
- QLGN $3.95
- ICCT $2.25
- Resistance Level
- QLGN $4.21
- ICCT $2.52
- Average True Range (ATR)
- QLGN 0.27
- ICCT 0.19
- MACD
- QLGN 0.00
- ICCT 0.05
- Stochastic Oscillator
- QLGN 22.08
- ICCT 36.23
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.